Deep Track Capital, LP 13D and 13G filings for Structure Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 08:46 am Purchase | 2025-06-30 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 15,401,751 8.920% | 3,101,751 (+25.22%) | Filing |
| 2025-05-15 08:42 am Purchase | 2025-03-31 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 12,300,000 7.150% | 3,300,000 (+36.67%) | Filing |
| 2025-01-13 4:08 pm Purchase | 2025-01-06 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 9,000,000 5.240% | 8,100,000 (+900.00%) | Filing |
| 2024-02-14 08:45 am Sale | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 900,000 0.660% | -7,040,346 (-88.67%) | Filing |
| 2023-02-03 4:31 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital, LP | 7,940,346 7.610% | 7,940,346 (New Position) | Filing |